Bank Of Nova Scotia Acadia Pharmaceuticals Inc Transaction History

Bank Of Nova Scotia

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$13.01 - $27.22 $356,942 - $746,807	-27,436 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$20.94 - $27.5 $519,877 - $682,742	-24,827 Reduced 47.5%	27,436 $664,000
Q4 2021 Feb 11, 2022	BUY	$16.79 - $27.09 $395,186 - $637,617	23,537 Added 81.94%	52,263 $1.22 Million
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $99,193 - $155,704	6,286 Added 28.01%	28,726 $477,000
Q2 2021 Aug 12, 2021	BUY	$19.4 - $27.42 $435,335 - $615,304	22,440 New	22,440 $547,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.81B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.